These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10587278)

  • 1. Effectiveness and safety of benzodiazepines.
    Möller HJ
    J Clin Psychopharmacol; 1999 Dec; 19(6 Suppl 2):2S-11S. PubMed ID: 10587278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
    Chouinard G; Labonte A; Fontaine R; Annable L
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):669-73. PubMed ID: 6141609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders.
    Uhlenhuth EH; Balter MB; Ban TA; Yang K
    J Clin Psychopharmacol; 1999 Dec; 19(6 Suppl 2):23S-29S. PubMed ID: 10587281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The benzodiazepines use disorder].
    Kawano T; Inada K
    Nihon Rinsho; 2015 Sep; 73(9):1506-10. PubMed ID: 26394512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepines and anxiety disorders: a review for the practicing physician.
    Michael Kaplan E; DuPont RL
    Curr Med Res Opin; 2005 Jun; 21(6):941-50. PubMed ID: 15969894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benzodiazepines in the treatment of anxiety. The risks and alternatives].
    Trucco M
    Rev Med Chil; 1990 Nov; 118(11):1262-70. PubMed ID: 1983806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep disorders and anxiety: biochemical antecedents and pharmacological consequences.
    Leonard BE
    J Psychosom Res; 1994; 38 Suppl 1():69-87. PubMed ID: 7799254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management.
    Schweizer E; Rickels K
    Acta Psychiatr Scand Suppl; 1998; 393():95-101. PubMed ID: 9777054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychiatric problems in therapy with benzodiazepines].
    Linder M
    Schweiz Med Wochenschr; 1983 May; 113(18):654-8. PubMed ID: 6135254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases.
    Goodman WK; Charney DS; Price LH; Woods SW; Heninger GR
    Am J Psychiatry; 1986 Jul; 143(7):900-3. PubMed ID: 2872826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions.
    Bradwejn J
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S109-13. PubMed ID: 7905780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine discontinuation in generalized anxiety disorder.
    Gupta R; Gupta N; Avasthi A
    Am J Psychiatry; 2002 Feb; 159(2):321-2. PubMed ID: 11823290
    [No Abstract]   [Full Text] [Related]  

  • 14. Benzodiazepines: therapeutic, biological and psychosocial issues. Symposium summary.
    Freedman DX
    J Psychiatr Res; 1990; 24 Suppl 2():169-74. PubMed ID: 1980696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence.
    Posternak MA; Mueller TI
    Am J Addict; 2001; 10(1):48-68. PubMed ID: 11268828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the pharmacokinetics of anxiolytic drugs.
    Altamura AC; Moliterno D; Paletta S; Maffini M; Mauri MC; Bareggi S
    Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):423-40. PubMed ID: 23330992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug treatment of anxiety disorders].
    Corfdir C; Pelissolo A
    Rev Prat; 2019 Nov; 69(9):981-984. PubMed ID: 32237616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal.
    Klein E; Uhde TW; Post RM
    Am J Psychiatry; 1986 Feb; 143(2):235-6. PubMed ID: 2868666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reappraisal of benzodiazepines in the treatment of anxiety and related disorders.
    Starcevic V
    Expert Rev Neurother; 2014 Nov; 14(11):1275-86. PubMed ID: 25242262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical Pharmacology.
    Nelson J; Chouinard G
    Can J Clin Pharmacol; 1999; 6(2):69-83. PubMed ID: 10519733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.